Member Info for Asleep

What's the story with them? Sorry not up to speed.

Somebody is confident at £1.45.

I'm expecting a reversal back upwards this afternoon.

Has somebody got wind of the results hence SP down?

I hope the share price does not over react too negatively on the news of upto 200 jobs to from a workforce of 12,000. In fact the SP should increase given lower costs and higher profit. Get the bad news out the way before a set of good results.

Looking forward to an acceleration upwards in the lead up and on the day.

That's funny. Long term shareholder since 2021. Talk to Warren Buffett

Turning off computer. Lost £300 already. More downside to come today.

Not sure I'm looking forward to these results anyway. They said that they did not meet expectations. That is why they sold off the division. The market might see it as a negative 'short term' but if Eenergy can spell out plans for the future it might ok or a buying opportunity if it heads 5p ish

Who is going to buy the 166m shares? Any takers?

Back on trend under 2.5p. Giving money to charity here. That's the plus side.

Thankyou. 'expects' so not definitely. Businesses should under promise and over deliver in my opinion. Should have had it a few days ago and not late hopefully. Manage expectations.

Hi, which RNS / ?? Was the end of Feb statement.

Thanks

Hopefully soon.

All Asleep. Don't blame them.

A great appointment - David Lockwood - look at that experience, know-how and previous positions. Hopefully, he will help WG move forward to a decent valuation from where it is now.

Go on Hemo. Drop the funding RNS.

From limited research, Hemo need to wait 30 days, after which they can start a small trial on humans. This will be costly to meet the next phase requirements. Looking at £3m plus and a minimum of one year. Therefore, Hemo needs some backing if it stays independent. Those are my thoughts.

Well, bought in at 3.4p last Thursday on the back of reading this chat board to make a quick profit. Made a few quid, and sold out a chunk but kept some for the future just in case. Thought it might go up more but hey ho.

The pre clinical acceptance was almost guaranteed so was factored into the recent share price increase already.